Biopharma [Review]

      	Previous	 	Contents	 	Next
	Issues in Science and Technology  Librarianship
	Summer 2003

	DOI:10.5062/F49K4868



      

  Book Reviews
    Biopharma: Biopharmaceutical Products in the U.S.   Market
      Reviewed by
D. Lynn Koenig
  University of Kansas
  Lawrence, Kansas
dlynn@ukans.edu  
    


    

Rader, Ronald A. Biopharma: Biopharmaceutical Products  in the U.S. Market. 2nd Edition, 2003. ISBN: 0-9639573-2-5 Price:  $240 plus $15 Shipping and Handling
  
      This is the second edition of Biopharma, a reference book that contains  information about biopharmaceuticals in the United States. The first edition, as well  as a revised first edition, was published in 1991. The author, who is also the  publisher, edited The Federal Bio-technology Transfer Directory in 1994.  This book serves as an encyclopedia for pending, as well as all approved,  biopharmaceuticals.  There is also an examination of things that have been previously  approved and controversial, but these products are not analyzed as much in depth as  the current biopharmaceuticals.    The target audience for this particular book would be someone doing research on a  particular biopharmaceutical who needed a lot of in-depth information without having  to go to many different sources. This book is a good compilation of information.

    This publication is very worthwhile. The author states that this book should not be  used to give medical or health care advice or information; it is strictly a  pharmaceutical reference tool. With that said, the information that it contains is in  depth and detailed. The book is well written and very well researched. The author  does a good job laying out the information. Some of the entries include vaccine  products, toxins, and insulin products. The web site for the book has some sample  entries.

    There are useful tools such as a very extensive table of contents and very  detailed indexes, such as: a state index, a company index, a chemical  index and a medical index. The user will be able find information quickly  and easily. At the front of the book there is also a user guide that can  be very useful. It explains to the user how the book is arranged and talks  about the importance of entry numbers.

    Each individual entry is well defined with the use of bold headings and  subheadings. For example, each entry contains an entry number and title,  what the main names are, a description and history when available, as well  as the status and other important information about the particular  pharmaceutical, including the manufacturers involved.

    One thing that is very valuable about this book is, that for some of the  entries, the author has taken the time to provide the user with additional  reading and sources that he or she could use for further research.

    This book is not for the lay person wanting to know about current pharmaceuticals on  the market. Much of the information contained in this book is extremely difficult for  the non-professional person to understand, but this reference would more than likely  be used by professionals who were already familiar with the field before using this  book. Since it is expensive, it is not necessarily appropriate for all libraries.

      

  

  	Previous	 	Contents	 	Next